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Sir, 
The widespread and relentless progression of skeletal muscle weakness secondary to motor neuronal 
degeneration in amyotrophic lateral sclerosis (ALS) is all the more striking in the relative preservation 
of those motor neurons subserving oculomotor function and continence. The molecular and broader 
physiological basis for selective neuronal vulnerability in ALS remains a subject of intense study and 
speculation. We note significant similarities with the pattern of muscle involvement associated with 
rapid eye movement (REM) sleep, raising the possibility of shared motor networks and so novel 
avenues for study. 
The stage of normal sleep associated with REM involves a temporary but profound state of motor 
paralysis during which there is, by definition, preservation of eye movements, and also continence. 
Respiration enters a more wakeful pattern of activity with the REM sleep state (1) and  the 
observation that respiratory insufficiency is typically a late-stage feature is consistent with its relative 
sparing in ALS, so that the increased respiratory activity noted in healthy REM sleep is compatible 
with the hypothesis of shared motor networks. Eventual diaphragmatic weakness is associated with 
shorter duration of REM sleep in ALS (2), and there is additional pathological extension to involve 
potentially REM-controlling brainstem areas in ALS, with Bunina bodies and TDP-43 inclusions (both 
with high specificity for ALS) found respectively within the locus coeruleus (3) and in the reticular 
formation of severely paralysed individuals (4). MRI studies have revealed progressive brainstem 
medullary morphometric atrophy in ALS (5), and more widespread cortical influences on the pattern-
generating circuits of the pre-Bötzinger complex have been postulated (6), which might 
independently increase respiratory network vulnerability in more advanced ALS. 
Spontaneous middle ear muscle activity is also found in REM sleep (7), with hearing-associated 
musculature also being spared in ALS (although mildly abnormal stapedial reflexes were noted in a 
sub-group of patients with bulbar involvement, presumably reflecting a greater brainstem 
pathological burden (8, 9)). Onuf’s nucleus is part of the somatic cell column, and partial denervation 
in the external anal sphincter and Onuf motor cells is observed early in ALS (10). Despite such early 
involvement, incontinence is not a feature of ALS. Similar findings exist with regard to the cardiac 
oesophageal sphincter, and the abductor muscles of the larynx, though reflux and stridor are not a 
feature of the disease, in keeping with the observation that REM sleep-active neuronal groups are 
relatively spared.   
The neuronal circuitry governing REM sleep involves glutamatergic neurons of the sublaterodorsal 
(SLD) nucleus in the region of the pontine tegmentum (11), and inhibitory hyperpolarization of 
ventromedial medullary and spinal cord lower motor neurons by glycinergic neurons (12). GABA-ergic 
projections from the tegmental area may exert an important control over the REM-atonia neurons of 
the SLD, inhibiting their activity in wakefulness (13). A consistent pathological hallmark of the peri- 
and early symptomatic phases of ALS is increased cortical excitability (14), which has been linked 
across a range of experimental platforms to a relative reduction of inhibitory versus excitatory 
interneuronal influences ((15, 16)), including brainstem interneuronal circuits (17), but also potential 
spinal inhibitory influences (18). The observation that REM sleep appears to reversibly disable the 
motor pathways preferentially targeted by ALS, while preserving functions that are relatively spared, 
may be further evidence for an imbalance of inhibitory versus excitatory interneuronal influences at 
the heart of ALS pathogenesis. Therapeutic strategies specifically targeting its restoration and 
biomarkers based on such phenomena are worthy of focused study (19). 
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